The once-daily pill combines Opko’s long-acting GLP-1/glucagon dual agonist peptide, dubbed OPK-88006, with Entera’s N-Tab ...

Wegovy is a prescription medication designed for chronic weight management, offering hope to individuals struggling with ...

As the potential of GLP-1 agonists for addiction gains traction, big pharma is also starting to take notice, namely the two ...

This story mentions weight, weight loss, and/or GLP-1 drugs. In the last few years, GLP-1s, prescription weight loss ...

Very few people are currently being prescribed drugs for weight loss on the NHS in Scotland, research by BBC Scotland News ...

Dr Jack and his mother Dr Clare Bailey Mosley are publishing new books as they continue Dr Michael Mosley's work ...

The US Department of Agriculture announced it will allocate $100 million to develop vaccines and other therapies to help ...

Novo Nordisk is lowering the price of its weight-loss drug Wegovy to $499 per month for some patients paying out of pocket.

Eli Lilly is offering vials of its weight-loss drug Zepbound to patients at a discount — but only if they skip their ...

Eli Lilly is offering vials of its obesity drug Zepbound to patients at a discount — but only if they skip their insurance.

Wegovy is FDA approved for weight management in certain children ages 12 years and older. The recommended dosage is the same as for adults. This is described in the table. Wegovy and Mounjaro can ...

New York, USA, Feb. 27, 2025 (GLOBE NEWSWIRE) -- WEGOVY Marks Significant Growth in Market Share Across the 7MM for Obesity Treatment | DelveInsight The WEGOVY market has experienced significant ...